TRPM2 and gastric cancer: We recently described the calcium-permeable Transient Receptor Potential Melastatin-2 (TRPM2) channel as a prognsostic marker in a cohort of GC patients and demonstrated its role in the bioenergetics and survival of GC cell lines17.